LBP-014 HBsAg loss and seroconversion after 16-week or 24-week AHB-137 treatment in HBeAg-negative chronic hepatitis B participants on NA therapy: results from an ongoing multicenter, randomized phase IIb study

Yanhang Gao, Junqi Niu, Youwen Tan et al.|Journal of Hepatology|2025

Cited by 2